ARTV earnings

10 reported quarters.

Next report expectedComing soon

Scheduled future earnings dates aren't available for this symbol yet. This is a planned addition, not a gap we expect to leave open.

Reported quarters10 quarters


FY2026 Q2	-	-$0.63	-	-	-	-	-
FY2026 Q1	-	-$0.95	-	-	-	-	-
FY2025 Q3	-	-$0.88	-	-	-	-	-
FY2025 Q2	-	-$0.87	-	-	-	-	-
FY2025 Q1	-	-$0.83	-	-	-	-	-
FY2024 Q3	-	-$0.92	-	-	-	-	-
FY2024 Q2	-	-$22.00	-	-	-	-	-
FY2024 Q1	-	-$17.24	-	-	251K	-	-
FY2023 Q3	-	$1.62	-	-	26.66M	-	-
FY2023 Q2	-	-$14.09	-	-	3.5M	-	-

Ask about Artiva Biotherapeutics, Inc.

The assistant answers from what ARTV has actually filed: 3 annual reports filed with the SEC, 57 Form 4 filings from the last year, 13F positions from the 1 tracked investor who hold it and 2 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from ARTV's filings and figures. One a day without an account; a free account has its own, and no card.

Follow ARTV from one quarter to the next, not one at a time.

Ten seconds, no card, and nothing to cancel.

No card, no broker connection.

Continue with Google

What an account lets you do with ARTV's results

These figures come from the company’s own quarterly SEC filings. The fourth quarter is derived (the annual figure minus the first three) and its EPS is left blank rather than estimated. Past results say nothing about future ones, and none of this is investment advice.

Every filed quarter, not just the last two years
The whole quarterly run ARTV has on file, with a trailing-twelve-month line drawn over it.
Quarterly statementsMeasure
The margins underneath the headline number
Gross, operating and net margin by quarter, so growth and a genuinely better business get told apart.
The full statementsMeasure
Ask what a quarter actually changed
Whether a move was the business or just the calendar, checked against ARTV's own history.